China Unveils Measures to Boost Foreign Investment in R&D Centers
The Ministry of Commerce and Ministry of Science and Technology, with the agreement of the...
Policy / Regulatory
China’s NHC Issues Guidelines to Improve Pediatric Medication Management
The National Health Commission (NHC) has released a notification aimed at refining management measures for...
China’s Multi-Bureau Plan Aims to Eradicate Cervical Cancer by 2030
The National Health Commission (NHC), Ministry of Education, Ministry of Civil Affairs, and six other...
NMPA Proposes Emergency Use Management Measures for Medical Devices
The National Medical Products Administration (NMPA) has released the “Medical Device Emergency Use Management Measures”...
China Updates Export Controls on Technologies, Adds Gene Editing to List
The Ministry of Finance (MOF) has released an updated notification regarding technologies banned and restricted...
NHSA Updates 2022 National Reimbursement Drug List with 2,967 Drug Varieties
The National Healthcare Security Administration (NHSA) has revealed the results of the 2022 National Reimbursement...
NHSA Completes 2022 NRDL Update with 111 New Listings, Focus on COVID-19 Treatments
The National Healthcare Security Administration (NHSA) held a press conference to mark the completion of...
China’s NHC Releases Second National Drug Use Monitoring List
China’s National Health Commission (NHC) has released the second national drug use monitoring list, covering...
China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs
The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round...
China’s Dental Implant VBP Tender Results in Significant Price Cuts
The results of the dental implant system-focused volume-based procurement (VBP) tender held in Sichuan have...
CDE Releases 66th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 66th batch of chemical generic reference...
China Meheco Keyi Pharma’s Ganciclovir Loses VBP Bid After Inspection Failure
The national drug alliance procurement office has released a notification indicating that China Meheco Keyi...
NMPA Releases 63rd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 63rd batch of reference drugs for...
NMPA Approves Expanded Production for COVID-19 Symptom Treatments
The National Medical Products Administration (NMPA) has approved filings from multiple companies to expand manufacturing...
China Optimizes Medical Insurance Policies for COVID-19 Treatment
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center...
Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
The National Reimbursement Drug List (NRDL) negotiations have concluded, with Pfizer’s (NYSE: PFE) COVID-19 therapy...
China Strengthens COVID-19 Prevention and Control in Rural Areas
China has intensified its COVID-19 prevention and control measures in rural areas, with the State...
China’s National Health Commission Releases Updated COVID-19 Treatment Plan
The National Health Commission (NHC) has released the 10th edition of the national COVID-19 Diagnosis...
NMPA Strengthens Oversight of COVID-19 Drugs and Home Treatment Guidelines
The National Medical Products Administration (NMPA) has released a notification aimed at enhancing the quality...
China’s NHC and NATCM Launch Integrated Pain Management Pilot Plan
The National Health Commission (NHC) and the National Administration of Traditional Chinese Medicine (NATCM) have...